Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,595
-$11,006 QoQ
Shares Held
8
-70.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#4,581
of 4,605 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTMENT COUNSEL CO OF NEVADA holds $48,110 across 4 Drug Manufacturers - General names. LLY ranks #2 (19.9% of the industry book) .
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,595 | 8 | Shares | Sole | 2026-08-10 | |
| 2025-09-30 | $20,601 | 27 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,047 | 27 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $85,894 | 104 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $80,288 | 104 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||